Eam Investors, LLC Repligen Corp Transaction History

Eam Investors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $1.3 Million - $1.63 Million	-7,191 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$148.08 - $206.57 $122,758 - $171,246	-829 Reduced 10.34%	7,191 $1.38 Million
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $377,208 - $487,313	-3,079 Reduced 27.74%	8,020 $1.18 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $1.15 Million - $1.71 Million	-12,160 Reduced 52.28%	11,099 $1.37 Million
Q1 2020 May 13, 2020	BUY	$84.96 - $109.14 $630,233 - $809,600	7,418 Added 46.83%	23,259 $2.25 Million
Q4 2019 Feb 11, 2020	SELL	$73.84 - $93.08 $135,717 - $171,081	-1,838 Reduced 10.4%	15,841 $1.47 Million
Q3 2019 Nov 13, 2019	SELL	$76.65 - $95.51 $474,616 - $591,397	-6,192 Reduced 25.94%	17,679 $1.36 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $1.29 Million - $2.05 Million	23,871 New	23,871 $2.05 Million
Q1 2019 May 13, 2019	SELL	$49.45 - $62.8 $1.97 Million - $2.5 Million	-39,877 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $1.33 Million - $1.9 Million	-27,584 Reduced 40.89%	39,877 $2.1 Million
Q3 2018 Nov 08, 2018	BUY	$46.8 - $58.97 $3.16 Million - $3.98 Million	67,461 New	67,461 $3.74 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.